USE OF OMEGA-3 POLYUNSATURATED FATTY ACIDS FOR THE TREATMENT AND PREVENTION OF HEART RHYTHM DISORDERS: WE ARE AT THE BEGINNING OF THE WAY
- Authors: Fomin VV1, Fomin VV1
-
Affiliations:
- Issue: No 7 (2012)
- Pages: 9-11
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/279482
- ID: 279482
Cite item
Full Text
Abstract
The article discusses the significance of ω3-polyunsaturated fatty acids (ω3-PUFAs) in the treatment and prevention of heart rhythm disorders. Data from studies of the effectiveness of ω3-PUFAs in the treatment of hypertriglyceridemia, and the prevention of ventricular arrhythmias and atrial fibrillation are presented. Improvement of long-term prognosis, including by reducing the risk of sudden death, was shown in patients with myocardial infarction and treated with ω3-PUFAs.
References
- Riccioni G, Bucciarelli T, Manchini B, et al. Antioxidant vitamin supplementation in cardiovascular disease. Ann Clin Lab Sci 2007;37(1):89-95.
- Lonn E, Yusuf S, Hoogwerf B, et al.; HOPE Study; MICRO-HOPE Study. Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy. Diabetes Care 2002;25(11):1919-27.
- Lonn E, Bosch J, Yusuf S, et al.; HOPE and HOPE-TOO Trial Investigators. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA 2005;293(11):1338-47.
- De Caterina R, Madonna R, Zucchi R, La Rovere MT. Antiarrhythmic effects of omega-3 fatty acids: from epidemiology to bedside. Am Heart J 2003;146(3):420-30.
- Gissi-HF Investigators, Tavazzi L, Maggioni AP, Marchioli R, et al. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 2008;372(9645):1223-30.
- Finzi AA, Latini R, Barlera S, et al. Effects of n-3 polyunsaturated fatty acids on malignant ventricular arrhythmias in patients with chronic heart failure and implantable cardioverter-defibrillators: A substudy of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca (GISSI-HF) trial. Am Heart J 2011;161(2):338-43.
- Bacova B, Radosinska J, Knezl V, et al. Omega-3 fatty acids and atorvastatin suppress ventricular fibrillation inducibility in hypertriglyceridemic rat hearts: implication of intracellular coupling protein, connexin-43. J Physiol Pharmacol 2010;61(6):717-23.
- Viljoen A, Wierzbicki AS. Diagnosis and treatment of severe hypertriglyceridemia. Expert Rev Cardiovasc Ther 2012;10(4):505-14.
- Pieke B, von Eckardstein A, Gülbahçe E, et al. Treatment of hypertriglyceridemia by two diets rich either in unsaturated fatty acids or in carbohydrates: effects on lipoprotein subclasses, lipolytic enzymes, lipid transfer proteins, insulin and leptin. Int J Obes Relat Metab Disord 2000;24(10):1286-96.
- Junker R, Pieke B, Schulte H, et al. Changes in hemostasis during treatment of hypertriglyceridemia with a diet rich in monounsaturated and n-3 polyunsaturated fatty acids in comparison with a low-fat diet. Thromb Res 2001;101(5):355-66.
- Saravanan P, Davidson NC, Schmidt EB, Calder PC. Cardiovascular effects of marine omega-3 fatty acids. Lancet 2010;376(9740):540-50.
- Sorice M, Tritto FP, Sordelli C, et al. N-3 polyunsaturated fatty acids reduces post-operative atrial fibrillation incidence in patients undergoing "on-pump" coronary artery bypass graft surgery. Monaldi Arch Chest Dis 2011;76(2):93-8.
- Nodari S, Triggiani M, Campia U, et al. N-3 polyunsaturated fatty acids in the prevention of atrial fibrillation recurrences after electrical cardioversion: a prospective, randomized study. Circulation 2011;124(10):1100-06.
- Kumar S, Sutherland F, Rosso R, et al. Effects of chronic omega-3 polyunsaturated fatty acid supplementation on human atrial electrophysiology. Heart Rhythm 2011;8(4):562-68.
- Ghio S, Scelsi L, Latini R, et al.; GISSI-HF investigators. Effects of n-3 polyunsaturated fatty acids and of rosuvastatin on left ventricular function in chronic heart failure: a substudy of GISSI-HF trial. Eur J Heart Fail 2010;12(12):1345-53.
- Marchioli R, Barzi F, Bomba E, et al.; GISSI-Prevenzione Investigators. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation 2002;105(16):1897-903.
Supplementary files
